Northern Trust’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.4M | Buy |
631,542
+52,236
| +9% | +$3.36M | 0.01% | 1224 |
|
|
2026
Q1 | $32.6M | Buy |
579,306
+1,578
| +0.3% | +$103K | ﹤0.01% | 1377 |
|
|
2025
Q4 | $46.3M | Sell |
577,728
-24,650
| -4% | -$1.66M | 0.01% | 1154 |
|
|
2025
Q3 | $29.4M | Sell |
602,378
-33,032
| -5% | -$2.04M | ﹤0.01% | 1449 |
|
|
2025
Q2 | $47.4M | Sell |
635,410
-16,008
| -2% | -$1.06M | 0.01% | 1133 |
|
|
2025
Q1 | $41.4M | Sell |
651,418
-26,843
| -4% | -$1.83M | 0.01% | 1204 |
|
|
2024
Q4 | $53M | Buy |
678,261
+93,848
| +16% | +$7.54M | 0.01% | 1091 |
|
|
2024
Q3 | $47M | Sell |
584,413
-1,293
| -0.2% | -$104K | 0.01% | 1064 |
|
|
2024
Q2 | $48.5M | Buy |
585,706
+10,296
| +2% | +$906K | 0.01% | 1024 |
|
|
2024
Q1 | $49.1M | Sell |
575,410
-53,102
| -8% | -$4.17M | 0.01% | 1012 |
|
|
2023
Q4 | $53.7M | Sell |
628,512
-11,152
| -2% | -$964K | 0.01% | 960 |
|
|
2023
Q3 | $57.3M | Sell |
639,664
-9,474
| -1% | -$846K | 0.01% | 850 |
|
|
2023
Q2 | $55.3M | Buy |
649,138
+691
| +0.1% | +$58.4K | 0.01% | 895 |
|
|
2023
Q1 | $53.7M | Buy |
648,447
+2,367
| +0.4% | +$192K | 0.01% | 902 |
|
|
2022
Q4 | $50.8M | Sell |
646,080
-4,576
| -0.7% | -$368K | 0.01% | 917 |
|
|
2022
Q3 | $48.2M | Sell |
650,656
-11,524
| -2% | -$827K | 0.01% | 883 |
|
|
2022
Q2 | $43.2M | Sell |
662,180
-16,202
| -2% | -$959K | 0.01% | 975 |
|
|
2022
Q1 | $42.9M | Sell |
678,382
-28,674
| -4% | -$1.56M | 0.01% | 1135 |
|
|
2021
Q4 | $37.5M | Sell |
707,056
-6,250
| -0.9% | -$381K | 0.01% | 1311 |
|
|
2021
Q3 | $50.4M | Buy |
713,306
+774
| +0.1% | +$48.8K | 0.01% | 1069 |
|
|
2021
Q2 | $47.5M | Buy |
712,532
+274,322
| +63% | +$19.4M | 0.01% | 1186 |
|
|
2021
Q1 | $48.6M | Buy |
438,210
+31,518
| +8% | +$3.9M | 0.01% | 1142 |
|
|
2020
Q4 | $48.3M | Sell |
406,692
-3,159
| -0.8% | -$340K | 0.01% | 1100 |
|
|
2020
Q3 | $35.8M | Sell |
409,851
-13,895
| -3% | -$1.21M | 0.01% | 1149 |
|
|
2020
Q2 | $38M | Sell |
423,746
-401,532
| -49% | -$40.6M | 0.01% | 1094 |
|
|
2020
Q1 | $82.2M | Sell |
825,278
-1,322
| -0.2% | -$143K | 0.02% | 555 |
|
|
2019
Q4 | $95M | Sell |
826,600
-16,011
| -2% | -$1.94M | 0.02% | 614 |
|
|
2019
Q3 | $106M | Buy |
842,611
+7,024
| +0.8% | +$892K | 0.03% | 558 |
|
|
2019
Q2 | $101M | Buy |
835,587
+4,458
| +0.5% | +$439K | 0.02% | 576 |
|
|
2019
Q1 | $72.7M | Buy |
831,129
+3,753
| +0.5% | +$341K | 0.02% | 707 |
|
|
2018
Q4 | $82.8M | Sell |
827,376
-9,866
| -1% | -$1.04M | 0.02% | 582 |
|
|
2018
Q3 | $95.9M | Sell |
837,242
-2,283
| -0.3% | -$236K | 0.02% | 571 |
|
|
2018
Q2 | $75.3M | Buy |
839,525
+155,454
| +23% | +$13.1M | 0.02% | 709 |
|
|
2018
Q1 | $50M | Buy |
684,071
+7,372
| +1% | +$506K | 0.01% | 1000 |
|
|
2017
Q4 | $39.3M | Sell |
676,699
-5,571
| -0.8% | -$293K | 0.01% | 1179 |
|
|
2017
Q3 | $30.6M | Sell |
682,270
-6,310
| -0.9% | -$262K | 0.01% | 1366 |
|
|
2017
Q2 | $27.2M | Buy |
688,580
+55,511
| +9% | +$2.28M | 0.01% | 1440 |
|
|
2017
Q1 | $25.7M | Buy |
633,069
+6,621
| +1% | +$259K | 0.01% | 1458 |
|
|
2016
Q4 | $25.2M | Sell |
626,448
-179,670
| -22% | -$6.77M | 0.01% | 1428 |
|
|
2016
Q3 | $29.2M | Buy |
806,118
+45,916
| +6% | +$1.58M | 0.01% | 1267 |
|
|
2016
Q2 | $22M | Buy |
760,202
+75,905
| +11% | +$2.29M | 0.01% | 1447 |
|
|
2016
Q1 | $23.7M | Buy |
684,297
+12,330
| +2% | +$398K | 0.01% | 1363 |
|
|
2015
Q4 | $21.7M | Buy |
671,967
+17,722
| +3% | +$575K | 0.01% | 1449 |
|
|
2015
Q3 | $21.1M | Buy |
654,245
+2,176
| +0.3% | +$81.9K | 0.01% | 1455 |
|
|
2015
Q2 | $27M | Sell |
652,069
-17,897
| -3% | -$754K | 0.01% | 1340 |
|
|
2015
Q1 | $30.1M | Sell |
669,966
-2,144
| -0.3% | -$89.6K | 0.01% | 1262 |
|
|
2014
Q4 | $25.1M | Sell |
672,110
-24,473
| -4% | -$896K | 0.01% | 1357 |
|
|
2014
Q3 | $24.3M | Buy |
696,583
+44,264
| +7% | +$1.58M | 0.01% | 1343 |
|
|
2014
Q2 | $23M | Sell |
652,319
-135,046
| -17% | -$4.51M | 0.01% | 1407 |
|
|
2014
Q1 | $25.7M | Buy |
787,365
+29,284
| +4% | +$1.12M | 0.01% | 1359 |
|
|
2013
Q4 | $31.9M | Sell |
758,081
-21,732
| -3% | -$894K | 0.01% | 1116 |
|
|
2013
Q3 | $31.1M | Sell |
779,813
-19,386
| -2% | -$813K | 0.01% | 1073 |
|
|
2013
Q2 | $33M | Buy |
+799,199
| New | +$32.4M | 0.01% | 966 |
|
Other funds holding HAE
AI
Northern Trust's HAE Position: Q2 2026 in Review
Northern Trust increased its Haemonetics (HAE) stake by 9% in Q2 2026, buying an estimated $3.36M and bringing the position to 631,542 shares worth $47.4M. The position accounts for 0.01% of the portfolio, ranked #1224.
Northern Trust first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Northern Trust held 631,542 shares of Haemonetics worth $47.4M as of Q2 2026.
- Northern Trust bought 52,236 Haemonetics shares in Q2 2026, an estimated $3.36M.
- Haemonetics made up 0.01% of Northern Trust's portfolio in Q2 2026, its #1224 holding.
- Northern Trust first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Northern Trust's Haemonetics position peaked at $106M in Q3 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.